Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Germinator Mobile Sanitizing and Disinfecting Expands to Kansas City


Photo of the owner of Germinator Kansas City

Germinator Kansas City will be owned and operated by Steve Kurtz, who brings a strong background in business ownership and management to the company.

I am proud to be a part of the Germinator team to provide an essential service to the members of my community, said Steve Kurtz.

Germinator Mobile Sanitizing and Disinfecting, a broad-spectrum disinfection, sanitizing and deodorization provider, is continuing to rapidly grow across the United States. The company is pleased to announce its expansion into the state of Missouri, opening a location in Kansas City.

Germinator Kansas City will be owned and operated by Steve Kurtz, who brings a strong background in business ownership and management to the company. A native of Lee’s Summit, Kurtz is a Mechanical Engineering graduate of Missouri University of Science & Technology. He spent the early part of his career in manufacturing management in the carpet industry before purchasing two HVAC companies and starting a One Hour Heating & Air Conditioning franchise in 2008. Kurtz has grown his business from scratch and was named a Top 25 franchisee in 2020 by the One Hour Heating & Air Conditioning group within Authority Brands. He decided to open a Germinator franchise to fill a need in the market for effective sanitizing and disinfecting so that he can provide businesses and residents throughout his community with a new generation of microbial protection.

“I am proud to be a part of the Germinator team to provide an essential service to the members of my community,” said Kurtz. “I first started looking into sanitizing and disinfecting companies after many of my heating and air conditioning clients would bring up concerns regarding the best ways to help keep their environments secure from germs, bacteria and viruses. Germinator is the best in the business. Their methods are proven effective and they put a very high value on professionalism and the highest quality customer service. I’m looking forward to launching the Kansas City franchise.”

Germinator was founded by Jeff Gill in 2015 with the mission of providing an effective method of sanitizing and disinfecting. The company launched national franchising in December 2019 and continues to rapidly expand across the country.

“Steve is the perfect addition to spearhead our launch into Missouri,” said Gill. “He has a proven track record of leading successful companies, and he has established strong relationships throughout Kansas City and beyond. We are proud to welcome him to the Germinator family.”

Germinator’s patent-pending methodology is the most unique and cost-effective means of providing enhanced antimicrobial protection for businesses and residences. The company first tests surfaces for ATP using a luminometer to detect light that can come from cellular activity. This measurement immediately provides the level of clean on a surface.

The next step is the application of Germinator’s Genesis surface treatment. Genesis is a one-step cleaner and broad-spectrum sanitizer and disinfectant treatment that harnesses the power of hypochlorous acid (HOCl). Derived from naturally occurring minerals, Genesis not only eliminates odors at their source, but kills a wide range of bacteria including Staphylococcus aureus, MRSA, Salmonella enterica and Pseudomonas aeruginosa, and viruses including norovirus, rotavirus and adenovirus on hard, non-porous, environmental surfaces. It meets the Association of Official Agricultural Chemists (AOAC) germicidal spray standards for Hospital Grade Disinfection and is on the EPA’s N List of products determined to meet the criteria for use against SARS-CoV-2, the virus that causes COVID-19. As a result, this treatment will eliminate bacteria and viruses that may reside in your home or business without the use of harsh chemicals or fumes.

Following Genesis, Germinator applies its Shield, a water-based quaternary ammonium compound that imparts a durable bacteriostatic finish. It is EPA-registered as effective against mold, mildew, algae and odor-causing bacteria. This application creates an invisible barrier that combats deterioration and discoloration and promotes freshness for up to three months.

The Genesis and Shield products are applied by using an electrostatic sprayer, which is the most efficient and effective means of delivering the products to the intended application sites. After Germinator’s surface treatment and protectant services, the company retests ATP levels to ensure the surfaces have achieved the intended results.

Upholding the highest standards of sanitization and disinfecting, Germinator makes claims that are scientifically supported and within EPA regulations. Germinator’s research and process are validated by the Germinator Scientific Advisory Board. The board is made up of key leaders such as Dr. Roscoe M. Moore, Jr. —who was an Assistant to the United States Surgeon General for five administrations; Dr. Harold Smith, who has extensive expertise in cell biology, molecular biology and biochemistry, along with decades of experience leading sponsored research on infectious diseases for the National Institutes of Health (NIH); Dr. David Miller, the Protocol Chair of University of Rochester Center for AIDS Research Community Advisory Board; and Chad S. Johnson, Esq., a Harvard-trained corporate, legislative, and regulatory attorney with significant experience in advising health and biotechnology companies.

“During these unprecedented times, the need to focus on sterilizing agents within our country’s airports, public spaces and offices in order to decrease the spread of viral pathogens such as Coronavirus is essential,” states Dr. Moore. “I am extremely happy to be a part of the Germinator team and lend my expertise in public health and regulatory affairs to what I feel is an immense asset to the containment effort.”

With Germinator, society can now have greater peace of mind and the freedom to live or work in a sanitized and disinfected environment. Businesses and residents in Kansas City can learn more by visiting https://www.germinatorkc.com/ or calling (816) 710-4376.

Share article on social media or email:

These Underrated Habits Are What You Need for Healthy Skin This Winter


Botanica Day Spa - Best Spa in Tampa - Gen Obolensky

Gen Obolensky, pictured here inside the spa’s Clearwater Beach-side locale, has led Botanica since 2004.

“Even if you can’t make your regular spa appointments, bringing regular self care into our daily routine at home is a positive thing.” -Gen Obolensky

Botanica Day Spa, a recognized leader in wellness and skincare for the last 25 years, is sharing safe and effective skincare rituals to try at home in the upcoming colder months.

Spa owner Gen Obolensky says not only is it possible to adapt spa-quality beneficial skincare to an at-home routine, but that she encourages it.

“The way 2020 went, it forced us all to look at our lives at home and to adapt and make changes. Even if you can’t make your regular spa appointments, bringing regular self care into our daily routine at home is a positive thing,” says Obolensky, who has been a practicing aesthetician and facialist since 2000. She has led the spa since 2004, and is now one of Pinellas County’s most sought-after skincare experts.

Mask-induced breakouts, commonly referred to as ‘maskne,’ and skin irritation are among the most common issues skincare enthusiasts are reporting this year, for obvious reasons.

“Adding in more hydration—not less—is often the key to mask breakout prevention, as well as easing into a routine that treats acne gently without stripping the skin’s natural barrier,” says Obolensky.

Skipping extremes, bumping up exfoliation and hydration are also on the list this season.

“During the winter months is when we sometimes find ourselves feeling like taking a hot shower, but this can be highly damaging and dehydrating to the skin, further exacerbating things. Instead, skip the hot shower and stick to tepid water on the face. Increasing exfoliative treatments in colder periods will enable the skin to more effectively absorb your efforts to hydrate,” she adds. “I can’t recommend enough the Enzymo-Spherides® Peeling Cream from the Pevonia line as an exfoliator. Pairing this with the Micro-Pores™ Bio-Active Serum can be really transformative to the skin.”

The spa carries these products and will continue to offer curbside service for anyone who needs it. They are also requesting the use of masks and adopting deep cleaning protocols in the spa indefinitely.

Fresh off recent local recognition from Creative Loafing as well as the Tampa Bay Times’ Best of the Best Awards, Botanica Day Spa recently expanded their 4,500 square foot oasis for relaxation in 2020. The spa, which now features a dedicated couples massage room, is a must-visit destination for visitors to Clearwater Beach.

To book an appointment at this local gem for a special occasion or a day of relaxation, contact 727-441-1711 or visit them online.

###

ABOUT BOTANICA DAY SPA

Botanica has been recognized as Clearwater’s leading day spa for more than 25 years, specializing in natural treatments for the body, skin and nails. The award-winning spa has been honored by Creative Loafing, CitySearch, Tampa Bay Times and others for exceptional standards in body treatments and therapeutic massage as well as manicures, pedicures and eyebrow shaping. Botanica’s menu of services features cutting edge beauty and wellness treatments with an emphasis on the use of organic and natural product lines. The stunning 4,500 square-foot facility is an oasis of relaxation and tranquility located in downtown Clearwater, Florida, accessible from the Pinellas Trail and just minutes from Clearwater Beach. For more information, please visit http://www.BotanicaDaySpa.com or on social media at @BotanicaDaySpa.

MEDIA CONTACT

Corina Froese

corina@dandelioncreativeco.com

727-441-1711

Share article on social media or email:

Resolving the Complexity of Cancer Heterogeneity, Upcoming Webinar Hosted by Xtalks


With the advent of single-cell genomic technologies, we can now interrogate cancer heterogeneity at a more fundamental level to enable more informed and potentially effective therapeutic strategies in clinical development.

In oncology therapeutic development and clinical intervention, partial responses and relapse are common phenomena and a significant impediment to effective treatments for patients. As our understanding of the complex biology of cancers continues to increase, we know that a significant contributor to these effects lies in cancers harboring a diverse collection of cells with distinct and dynamic molecular profiles. This feature of cancer heterogeneity manifests in several ways: intra- and inter-tumor, intra-cellular, as well as spatial and temporal differences.

With the advent of single-cell genomic technologies, we can now interrogate cancer heterogeneity at a more fundamental level to enable more informed and potentially effective therapeutic strategies in clinical development. In this webinar, featured speakers will discuss a specific platform capable of detecting genomic content from individual cells, thereby providing insights into cancer heterogeneity and response to specific therapeutics.

Join Steve Anderson, PhD, Chief Scientific Officer, Covance Drug Development; and Bin Wu, PhD, Senior Director, Head of Translational Medicine, Agios Pharmaceuticals, Inc., in a live webinar on Monday, December 14, 2020 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Single-Cell Genomics Applications in Oncology Therapeutic Development: Resolving the Complexity of Cancer Heterogeneity.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Sample Stabilization Approaches for Unstable Compounds in Biological Matrices, Upcoming Webinar Hosted by Xtalks


This presentation will cover some of the factors that contribute to analyte instability as well as strategies that can be used during sample collection and handling to achieve stability prior to analysis.

In order to obtain accurate and meaningful data, the analyte of interest must be sufficiently stable in the sample matrix. The stability should be proven covering the entire sample lifecycle: beginning from the time of collection until the last reported analytical result. There are many biological fluids that laboratories analyze, including plasma, serum, whole blood, urine, cerebral spinal fluid (CSF), as well as tissues such as skin, lung and brain. Each of these matrices can present stability challenges due to their varied endogenous components that can either help maintain analyte stability or be the culprit for instability. This presentation will cover some of the factors that contribute to analyte instability as well as strategies that can be used during sample collection and handling to achieve stability prior to analysis.

Join Corey Ohnmacht, Ph.D, Director of Science for Bioanalytical and Quality Control Laboratories, PRA Health Sciences, in a live webinar on Friday, December 11, 2020 at 11am EST (4pm GMT/UK).

For more information, or to register for this event, visit Stabilizing the Unstable: Sample Stabilization Approaches for Unstable Compounds in Biological Matrices.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Cellmyx welcomes new Chief Scientific Officer, Wangzhong Sheng, Ph.D.


Wangzhong (Wang) Sheng, Ph.D.

Wangzhong (Wang) Sheng, Ph.D.

Cellmyx is very excited to announce the appointment of Wangzhong (Wang) Sheng, Ph.D. as our new Chief Scientific Officer. Wang completed his degree at the University of California, San Diego, where he researched and developed innovative methods to improve upon conventional liposuction techniques for his dissertation.

Prior to joining Cellmyx, Wang was a Scientist at Bristol Myers Squibb, where he worked on developing innovative drugs for the treatment of cancer. Wang brings a wealth of knowledge in the biomedical, pharmaceutical, regenerative medicine, and cosmetic areas that will provide the infrastructure needed to continue advancing this company forward in the medical industry.

At Cellmyx, Wang will oversee the research and development of novel innovative products to add to our suite of proprietary medical technology products for the harvesting, processing, and deployment of autologous soft tissue, with focus on expanding the business into the regenerative medicine space. In addition to offering his scientific and business leadership, Wang will also serve as the Director of Clinical Operations, where he will leverage his prior experience to obtain regulatory clearance, both domestically and internationally, for some of our newest products.

ABOUT CELLMYX

Cellmyx designs, patents, and manufactures proprietary medical technology products for the harvesting, processing, and deployment of autologous soft tissue. “Cellmyx is where regenerative and aesthetic medical technologies meet. The science and engineering team at Cellmyx is committed to advancing the art of both aesthetic and regenerative medical applications. We see global market signals indicating that throughout the next decade, the growth in patient demand for natural regenerative medical solutions will outpace the desire for previous synthetic-only options. Our R&D pipeline is novel and uniquely positioned to meet this growing demand in the regenerative medicine space”, states Gregory Miles, CEO.

The company has developed patented technologies and proprietary products such as the AcquiCell™, Lipo- Loop®, and a full line of FDA compliant fat collection and transfer devices. Recently, Cellmyx has been having success with its intelliFat™ SVT kit for orthopedic and pain management. This transformative kit enables physicians to transfer the patient’s own adipose tissue quickly and efficiently, without a centrifuge, in an office-based or surgical setting, under local anesthesia. This eliminates the need for general anesthesia for many types of procedures, thereby reducing patient risk. The intelliFat™ SVT single use disposable kit provides physicians a method to harvest, process, and transfer in a closed system to achieve sterile and viable adipose tissue of varying cluster sizes, making low volume fat transfers safe, simple, and cost effective. To find out more about the intelliFat™ SVT kit, please visit intellifat.com.

In the near future, Cellmyx will be releasing a new sterile single-use SuperG® Micro cannula, designed for both manual extraction and power-assisted liposuction, to collect 500-micron clusters of adipose tissue. Stayed tuned to find out more!

For more information on our suite of products, please visit cellmyx.com or call (949) 215-8560.

Share article on social media or email:

The Toronto Institute of Pharmaceutical Technology Offers Online-Offline Delivery of Pharmaceutical Diploma Programs in 2021


News Image

The Toronto Institute of Pharmaceutical Technology has launched a unique online-offline combination for delivering its pharmaceutical industry diploma programs.

TIPT, established in 1992, has long been North America’s leading institute for pharmaceutical education and training and the first institute of its kind in Canada. After nearly 30 years of excellence in the field, the COVID-19 pandemic required TIPT to briefly move to virtual class delivery. This posed a unique challenge for the school, known across Canada and globally for its exclusive programs where students learn in a hands-on capacity within TIPT’s state-of-the-art GMP compliant and Health Canada-licensed laboratories. “We knew that students had to get back into the classroom, if at least only for the practical part of our programs’ curricula,” says Dr. Alexander MacGregor, Dean and President of TIPT. “We began to formulate a hybrid system that would allow for student safety as well as addressing the need for practical training. As soon as we received the go-ahead from the Ministry of Education, we put our plan into place.”

That plan is a hybrid online-offline curriculum for Pharmaceutical Diploma Programs that integrates virtual learning, online technology, and government approved hands-on, in-class learning. TIPT’s new model for students entering programs from January 2021 and beyond allows them to complete their theory curriculum from home using live video classes. The unique element comes through their practical curriculum, which is completed partly online by experiencing 360o virtual tours of the high-tech pharmaceutical machinery and is complimented by staggered small class cohorts completing their practical work on-campus.

Beyond that, the school has embraced the ‘technology’ part of its name by engaging in the development and implementation of a virtual reality component in online learning. With virtual reality, students will be able to don VR glasses and experience the handling of pharmaceutical equipment and machinery just as they would on-campus. “It was imperative that we find a solution to support our students with the same world-class experience they receive in our labs, even if they are studying remotely for the time being,” says MacGregor. “When we started exploring VR, we realized we could provide a simulation of our equipment to students as a preparatory measure, and help minimize the knowledge gap for when they are able to attend classes on-site.”

The Institute is working to develop a virtual reality solution to implement by spring 2021 as an addition to their already unique online-offline learning platform.

Share article on social media or email:

180 Medical Announces Recipient of The Ron Howell Caregiver Scholarship


News Image

Ron Howell built and led 180 Medical with a drive to achieve true excellence in all areas. As Yousra begins her college journey, we are confident that she too will pursue her studies with the same enthusiasm.

180 Medical, one of America’s leading providers of intermittent catheters, incontinence products, and ostomy supplies, is pleased to announce that Yousra Mohamed has become the first student to receive their new Caregiver Scholarship. This scholarship program aims to help college students who are currently unpaid caregivers of a family member or loved one with a chronic disability. These students frequently face limited financial resources as well as limited time for studying and gaining experience to enter their desired career path. Recognizing this, 180 Medical has opened this new annual scholarship program to aid these caregivers in their educational pursuits.

After a rigorous process of judging, 180 Medical proudly announced the very first recipient of the 180 Medical Caregiver Scholarship Program, Yousra Mohamed. Yousra has acted as a caregiver to her mother since an early age. Yousra credits her experience as a caregiver to her parent as a journey that “has filled me with empathy and motivation to pursue a future career in medicine.”

Yousra began her freshman year at the University of Southern California this fall with the help of the 180 Medical Ron Howell Caregiver Scholarship award of $1,000. She says, “Thank you for this generous scholarship. I am appreciative and truly honored.”

Mark Jassey, Chief Commercial Officer of 180 Medical, says, “We’re so proud to be able to assist Yousra with her goals through our new Caregiver Scholarship program. We’re sure her experience as a caregiver from such an early age will influence her dedication to care and compassion both at school, among her peers, and in her future career.”

The 180 Medical Ron Howell Caregiver Scholarship was named for 180 Medical’s former President, Ron Howell, who retired from 180 Medical after nearly 15 years of working to ensure we continue to uphold 180 Medical founder Todd Brown’s vision of providing the very best catheter, ostomy, and incontinence supplies along with the best possible service.

Seth Segel, President of 180 Medical, says, “Ron Howell built and led 180 Medical with a drive to achieve true excellence in all areas. As Yousra begins her college journey, we are confident that she too will pursue her studies with the same enthusiasm.”

In addition to 180 Medical’s role as a leading supplier of direct-to-home insurance covered medical supplies, 180 Medical also likes to give back to local communities across America to touch and help support others through charitable actions. The 180 Medical Ron Howell Caregiver Scholarship is another way to extend support to caregivers who want to use their experience to help change the world for the better.

180 Medical thanks all caregivers, including those who balance their collegiate studies with their care of a loved one. These students are true heroes, and the Ron Howell Caregiver Scholarship will continue to recognize these incredible individuals for years to come.

About 180 Medical:

180 Medical is one of America’s fastest-growing home delivery providers of intermittent catheters, ostomy products, incontinence supplies, and other related urologic disposable medical supplies. Based in Oklahoma City, the company is dedicated to meeting the supply needs of customers with diagnoses such as urinary incontinence, spinal cord injuries, spina bifida, colon cancer, Crohn’s disease, and many other conditions that require catheterization and ostomy supplies. 180 Medical is a subsidiary of ConvaTec, a leading global medical products and technologies company.

Share article on social media or email:

Mark S. Roisman, DMD of Westport, CT Announces New Infection Control Technology


Mark S. Roisman, DMD of Westport, CT

Mark S. Roisman, DMD of Westport, CT

We’ve been doing our utmost to minimize any risk to our patients, most significantly with the basics, including level 3 masks on top of N95 masks and underneath full-coverage face shields. Most importantly, every patient gets thoroughly screened.

Mark S. Roisman, DMD has always embraced state-of-the-art technology in his Westport, CT dental practice. When the COVID-19 pandemic upended standard practices at dentists’ offices across the world, Dr. Roisman pored over the latest infection control research and implemented new protocols to keep his patients safe whenever they visit for dental care.

“We’ve been doing our utmost to minimize any risk to our patients, most significantly with the basics, including level 3 masks on top of N95 masks and underneath full-coverage face shields. Most importantly, every patient gets thoroughly screened. Our protocol includes communicating by text with patients before they enter the office to avoid any cross-over in our waiting room. We have also contracted with a uniform service to provide us with enough surgical gowns so that we can change between patients (sometimes several times for the same patient),” Dr. Roisman says.

Dr. Roisman continues, “Making crowns in a single visit enables us to minimize the number of visits a patient may need, and digital impressions shorten appointments and can minimize intraoral procedures. These shorter visits and procedures minimize exposure which minimizes risk.”

As Dr. Roisman explains, “We must be doing a lot right — we’ve been reopened since May 20th in one of the highest risk professional environments relating to COVID without a single incident.”

At Dr. Roisman’s practice, tried-and-true infection control measures like N95 masks, face shields, gown changes, surface disinfection, gloves, and hand sanitizer are being combined with advanced air purification technology and the Nu-Bird evacuation system.

The Nu-Bird evacuation system addresses one of the most pressing concerns for dental practices during the COVID-19 pandemic—the aerosols produced during many standard dental procedures. Even a routine dental cleaning performed with ultrasonic tools can produce a fine mist of aerosols that can linger in the air and be inhaled by dentists, staff, and subsequent patients, potentially infecting them with coronavirus.

Nu-Bird works by suctioning aerosols during procedures, greatly reducing the amount released into the room. When combined with disinfecting rinses prior to treatment and air purification, the risk of infection is minimized.

In addition to using advanced infection control technology in his dental practice. Dr. Roisman was one of the first dentists in Connecticut to provide digital radiography to his patients and also to use the iTero digital impression scanner to design crown and bridge restorations. Patients in Westport appreciate being able to get state-of-the-art treatments from their hometown dentist.

About Mark S. Roisman, DMD

Dr. Mark S. Roisman has been providing exceptional care to patients in Westport, CT for over 20 years. He earned his degree in dentistry from the University of Pennsylvania School of Dental Medicine and enjoys keeping up-to-date on the latest dental technologies and techniques through continuing education. Dr. Roisman offers comprehensive dental services, including general dentistry, restorative dentistry, cosmetic dentistry, dental implants, pediatric dentistry, and sedation dentistry. To learn more, visit https://www.mywestportdentist.com or call 203-227-6338 to schedule a visit to Dr. Roisman’s office at 225 Main St., Suite 304, Westport, CT 06880.

Share article on social media or email:

Research Study Obtains 100% Sensitivity and Specificity for COVID-19 Serology with Support from Salimetrics


Salimetrics

This study illustrates that saliva, and how to collect it right, can facilitate widespread scalable surveillance with uncompromised sensitivity and specificity while providing practical, non-invasive sampling.

Recently, infectious disease experts at Johns Hopkins and Emory University, in collaboration with Salivary Bioscience experts from Salimetrics and the University of California, Irvine, published a preliminary report in the Journal of Clinical Microbiology for a saliva/oral fluid-based study related to COVID-19 immunology. At a critical juncture during the era of COVID-19, this promising research provides evidence that saliva can hold the key to population-wide sampling and further determine the magnitude and duration of the antibody response induced after infection. Data generated from saliva samples would also serve as an important step in large-scale monitoring and seroprevalence studies of SARS-CoV-2 infections.

The significance of this COVID-19 serology study was featured recently in a news release from the Johns Hopkins Bloomberg School of Public Health. Results from this study are the product of a long-standing collaboration between public health experts and Salimetrics who provided key technical knowledge and translational salivary bioscience expertise related to the collection, handling, and processing of saliva samples. “We actively share our 20 years of knowledge gained from investing in salivary R&D efforts,” says Steve Granger, Ph.D., Salimetrics Chief Scientific Advisor. “We’ve supported over 20,000 studies, and that experience has put Salimetrics at the leading edge of salivary bioscience methods. This study illustrates that saliva, and how to collect it right, can facilitate widespread, scalable surveillance with uncompromised sensitivity and specificity through practical, non-invasive sampling. A hurdle for serum sampling in surveillance studies, that can be overcome with saliva, is inherent bias due to samplings from admitted patients in hospitals or individuals willing to provide a blood sample. Saliva as an at-home collection option may enable true, unbiased sampling to determine the prevalence and incidence of disease in communities. It is a big step in the right direction, not only for saliva but for major scientific contributions that may directly help reduce the spread of infectious diseases like SARS-CoV-2.”

In the study, “COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva”, researchers obtained 100% sensitivity and specificity using non-invasive oral fluid sampling for detecting prior SARS-CoV-2 infection. “This is highly encouraging and indicates that saliva will play a prominent role in COVID-19 support efforts,” says Dr. Granger. “Supported with key scientific knowledge from Salimetrics, this study provides one more step to enable future research and application.”

In practice, saliva maintains the benefits of rapidly improving participant compliance, scalability, sampling frequency, and safety for both the participants and test administrators. In early May, the FDA approved the first home-based COVID-19 saliva test through emergency use authorization, which enabled healthcare workers to screen for active infections without the use of a nasopharyngeal swab. Since the first EUA for a saliva-based test was granted, several additional saliva tests have also been approved by the FDA, enabling diagnostic testing to continue at a record pace around the country. Now, seroprevalence studies will be necessary to facilitate knowledge in supporting appropriate COVID-19 relief efforts. “With so many unknowns still related to the COVID-19 pandemic, saliva’s flexibility to handle frequent self-sampling over long periods of time can allow researchers to answer many questions related to prevalence and immunity from SARS-CoV-2,” says Supriya Gaitonde, Ph.D., Salimetrics Senior Applications Scientist.

Successful application of this research has also backed the development of Salimetrics SARS-CoV-2, (N-Protein) Salivary IgG ELISA Kit. “We’ve mobilized our extensive expertise to enable researchers and public health officials to generate knowledge of COVID-19 infection/exposure history,” says Dr. Gaitonde. Using close coordination between colleagues and experts in immune-surveillance and SARS-CoV-2 immunology, Salimetrics’ SARS-CoV-2 IgG (N-protein) ELISA Kit was designed to be practical, non-invasive, and to fill the urgent need for large-scale monitoring or seroprevalence of coronavirus infections.

About Salimetrics:

Salimetrics assay kits and CLIA-certified testing services are used to measure salivary analytes related to stress, behavior and development, inflammation, sleep, reproduction, health and immune function. Founded in 1998 by Douglas A. Granger, Ph.D., Salimetrics, LLC supports CROs, pharmaceuticals, academic researchers and the immunodiagnostic industry around the world with innovative immunoassay products, non-invasive saliva collection methods, and laboratory testing services.

Share article on social media or email:

Tackling Inequities in Medicare Advantage


MA plans are at the forefront of this effort, not only addressing SDOH but also the underlying inequities inherent in our system, and only by addressing these disparities can we provide optimal care for all beneficiaries.

RAM Technologies, Inc., the perennial leader in the development of enterprise managed care software for Medicare Advantage and Special Needs health plans, is pleased to announce the availability of a new report as part of the “Sharing Knowledge to Improve Healthcare Administration” (SKIHA) program. This month, members of the SKIHA program (free registration) are granted complimentary access to the RAM report, Tackling Racial, Ethnic and Socioeconomic Inequities in Medicare Advantage.

Lack of access to safe housing, healthy food and transportation are an ongoing concern for some of today’s most vulnerable seniors. Recent conversations about ethnic and racial inequality have shone a light on these issues but there is still a lot of work to be done to overcome the effect discrimination, language barriers and racial disparities have on the delivery of healthcare to our elder population. Industry efforts to support social determinants of health (SDOH) have made the first move, however they cannot truly be effective until we understand and address the ways racism and socioeconomic inequities impact the healthcare experience.

“Health insurers all across the country have made sizable commitments to addressing health inequity; through outreach programs, SDOH initiatives and other innovative programs, but there is still more work to be done,” stated Christopher P. Minton, Executive Vice President of RAM Technologies, Inc. “MA plans are at the forefront of this effort, not only addressing SDOH but also the underlying inequities inherent in our system, and only by addressing these disparities can we provide optimal care for all beneficiaries.”

In order to drive change, it is more important than ever to address racial, ethnic and socioeconomic inequities in healthcare. Leveling the playing field in these areas offers the potential to not only improve outcomes, but also provide for a healthier and happier member base. This article takes a deeper look at the ways in which MA health plans can improve SDOH and provide optimal care for their members. To read the entire report, “Tackling Racial, Ethnic and Socioeconomic Inequities in Medicare Advantage”- CLICK HERE.

RAM Technologies is a leading healthcare software and services provider with nearly 40 years of experience delivering proven administrative solutions to the healthcare payer market, with a specific focus on simplifying the administration of Medicare Advantage. The RAM offering, Medicare Advantage-in-a-Box, powered by HEALTHsuite Advantage™ represents the leading end-to-end solution for health plans administering MA or looking for a simplified way to get into the MA market.

About the Program

Established in 2015, the SKIHA program (Sharing Knowledge to Improve Healthcare Administration), provides an open platform to share industry analysis and research, helping the payer community prepare for the future. Every month the SKIHA program makes available special content, with unique insight and in-depth industry knowledge, to those in the position to enact real change. This open exchange of ideas supplies the information health plans need to improve operations, increase productivity and reduce costs.

About RAM Technologies, Inc.

RAM Technologies is the leading provider of enterprise health claims processing software and CMS Integration tools for health care organizations administering Medicare Advantage and Special Needs plans. For almost 40 years RAM Technologies has led the way in the creation of benefit administration software for these programs and continues to enhance their auto adjudication software to meet the needs of a rapidly changing market. RAM Technologies has been recognized on Inc. Magazine’s List of Fastest Growing Private Companies and the Philadelphia Business Journal’s List of Top Software Developers for their advancements in the creation of comprehensive auto adjudication software for Medicare and SNP administration. To learn more about RAM Technologies’ healthcare claims processing solutions call (877) 654-8810 or visit http://www.ramtechinc.com.

Share article on social media or email: